GLP-1s can save health system money if priced below $350 a month: analysis

Résumé détaillé

CVS Health's Aetna claims analysis finds GLP-1s priced below $350 a month could yield net savings for payors through reduced health care use. Read more here.

An analysis of insurance claims data found that if GLP-1 medications for weight loss and diabetes are priced below $350, it results in net savings for payors, such as employers and plan sponsors, through reduced use of health care services that result.

Début de l'article, extrait de Seeking Alpha. Pour lire la suite, ouvrez l'article chez le média.